Mortality trends and disparities in ischemic heart disease with disorders of thyroid gland, United States,1999 to 2023: a CDC wonder database analysis
Journal of Diabetes & Metabolic Disorders · 11.03.2026 · 25 (1)
DOI: 10.1007/s40200-026-01931-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes & Metabolic Disorders, online erschienen am 11.03.2026. Verfasst von Jianren Wen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi University of Chinese Medicine, Nanchang, China. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: nnovation and Entrepreneurship Training Program for College Students, 2025 Jiangxi Science Education Society On-campus Research Project, Jiangxi Provincial Society for Science Education Graduate Student Research Project.
Abstract (Originalsprache)
Background
Ischemic heart disease (IHD) has remained the leading cause of death in the United States for over two decades, accounting for a large share of cardiovascular mortality. Thyroid disorders are known to worsen IHD progression, yet population-level evidence on their combined mortality burden is limited. This study leverages the CDC WONDER multiple-cause-of-death database to evaluate national trends and disparities in IHD mortality with coexisting thyroid disorders.
Methods
We analyzed death certificate data from 1999 to 2023 for adults aged ≥ 25 years with IHD and thyroid disorders. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated. Temporal trends were assessed using Joinpoint regression, yielding annual percentage change (APC) and average annual percentage change (AAPC).
Results
From 1999 to 2023, 170,740 deaths were attributed to IHD with thyroid disorders. The overall AAMR declined from 7.35 in 1999 to 5.34 in 2023 (AAPC = - 1.40). Joinpoint regression showed a steady decline from 1999 to 2017 (APC = - 2.80), a temporary rise during 2017-2021 (APC = + 6.68), and a subsequent decrease from 2021 to 2023 (APC = - 4.18). Men consistently had higher AAMRs than women (13.23 vs. 10.03). Mortality was highest among non-Hispanic Black individuals, adults aged ≥ 85 years (56.95), and residents of rural areas (7.95 vs. 5.22 in urban areas).
Conclusion
While overall mortality from IHD with thyroid disorders declined between 1999 and 2023, disparities by sex, race/ethnicity, age, and urban-rural status remain pronounced. These findings highlight the need for targeted prevention and intervention strategies to reduce inequities in this high-risk population. Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-026-01931-6.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Jiangxi University of Chinese Medicine, Nanchang, China.
- Shenzhen Hospital of Guangzhou University of Chinese Medicine, Shenzhen, China.
Förderung
- nnovation and Entrepreneurship Training Program for College Students
- 2025 Jiangxi Science Education Society On-campus Research Project
- Jiangxi Provincial Society for Science Education Graduate Student Research Project
- the National Natural Science Foundation of China
- Ganpo Talent Support Program - Training Program for Academic and Technical Leaders in Major Disciplines
Zitieren
APA
Wen, J., Hu, J., & Zou, G. (2026). Mortality trends and disparities in ischemic heart disease with disorders of thyroid gland, United States,1999 to 2023: a CDC wonder database analysis. Journal of Diabetes & Metabolic Disorders, 25(1). https://doi.org/10.1007/s40200-026-01931-6
Vancouver
Wen J, Hu J, Zou G. Mortality trends and disparities in ischemic heart disease with disorders of thyroid gland, United States,1999 to 2023: a CDC wonder database analysis. Journal of Diabetes & Metabolic Disorders. 2026;25(1). doi:10.1007/s40200-026-01931-6
BibTeX
@article{Wen2026,
author = {Wen, Jianren and Hu, Jingxuan and Zou, Guohui},
title = {Mortality trends and disparities in ischemic heart disease with disorders of thyroid gland, United States,1999 to 2023: a CDC wonder database analysis},
journal = {Journal of Diabetes & Metabolic Disorders},
year = {2026},
volume = {25},
number = {1},
doi = {10.1007/s40200-026-01931-6}
}
EUVIMED